Home

Case-control study of the parkin gene in early-onset Parkinson disease

Lorraine N. Clark; Shehla Afridi; Eric Karlins; Yuanjia Wang; Helen Mejia-Santana; Juliette Harris; Elan D. Louis; Lucien J. Cote; Howard F. Andrews; Stanley Fahn; Cheryl H. Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder

Title:
Case-control study of the parkin gene in early-onset Parkinson disease
Author(s):
Clark, Lorraine N.
Afridi, Shehla
Karlins, Eric
Wang, Yuanjia
Mejia-Santana, Helen
Harris, Juliette
Louis, Elan D.
Cote, Lucien J.
Andrews, Howard F.
Fahn, Stanley
Waters, Cheryl H.
Ford, Blair
Frucht, Steven
Ottman, Ruth
Marder, Karen
Date:
Type:
Articles
Department:
Center for Parkinson's Disease and Other Movement Disorders
Volume:
63
Permanent URL:
Book/Journal Title:
Archives of neurology
Abstract:
Background: Mutations in parkin are estimated to account for as much as 50% of familial Parkinson disease (PD) and 18% of sporadic PD. Single heterozygous mutations in parkin in both familial and sporadic cases may also increase susceptibility to PD. To our knowledge, all previous studies have been restricted to PD cases; this is the first study to systematically screen the parkin coding regions and exon deletions and duplications in controls. Objective: To determine the frequency and spectrum of parkin variants in early-onset PD cases (aged 50 years) and controls participating in a familial aggregation study. Patients and Methods: We sequenced the parkin gene in 101 cases and 105 controls. All cases and controls were also screened for exon deletions and duplications by semiquantitative multiplex polymerase chain reaction. Results: Thirteen (12.9% [95% confidence interval, 7%-21%]) of the 101 cases had a previously described parkin mutation: 1 was homozygous, 11 were heterozygous, and 1 was a compound heterozygote. The mutations Arg42Pro (exon 2) and Arg275Trp (exon 7) were recurrent. The previously reported synonymous substitution Leu261Leu (c.884A>G) was identified in 4 (3.9%) of 101 cases and 2 (2%) of 105 controls (P = .44). Excluding the synonymous substitution Leu261Leu (heterozygotes), 10 (9.9% [95% confidence interval, 4.6%-17.5%]) carried mutations. Conclusions: The frequency of mutations among cases that were not selected based on family history of PD is similar to what has previously been reported in sporadic PD. The similar frequency of Leu261Leu in cases and controls suggests it is a normal variant rather than a disease-associated mutation. We confirmed that heterozygous parkin mutations may increase susceptibility for early-onset PD.
Subject(s):
Neurosciences
Publisher DOI:
http://dx.doi.org/10.1001/archneur.63.4.548
Item views:
204
Metadata:
View

In Partnership with the Center for Digital Research and Scholarship at Columbia University Libraries/Information Services.